Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Genetic Associations and Epidemiology, Systemic Sclerosis and Related Diseases, Lung Cancer Treatments and Mutations, and Cancer Genomics and Diagnostics.
Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
Protein-altering germline mutations implicate novel genes related to lung cancer development
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Association Analysis of Driver Gene–Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls
Trans-ethnic genome-wide meta-analysis of 35,732 cases and 34,424 controls identifies novel genomic cross-ancestry loci contributing to lung cancer susceptibility
Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region
Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis
The IRF5–TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share
Identification of <i>IL12RB1</i> as a Novel Systemic Sclerosis Susceptibility Locus
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study